162 related articles for article (PubMed ID: 30288155)
1. Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Lu IT; Yeh HZ; Chang CS; Kao CH
Dose Response; 2018; 16(4):1559325818803283. PubMed ID: 30288155
[TBL] [Abstract][Full Text] [Related]
2. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chen CC; Kao CH
Front Pharmacol; 2018; 9():718. PubMed ID: 30018559
[No Abstract] [Full Text] [Related]
3. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
4. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
5. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study.
Yee J; Han HW; Gwak HS
Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788
[TBL] [Abstract][Full Text] [Related]
8. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
[No Abstract] [Full Text] [Related]
9. Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.
Kuo HY; Liang CS; Tsai SJ; Chen TJ; Chu CS; Chen MH
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886592
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study.
Li CY; Dai YX; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chen MH
Dermatology; 2021; 237(6):884-890. PubMed ID: 34474411
[TBL] [Abstract][Full Text] [Related]
11. Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study.
Wang YT; Tsai MC; Wang YH; Wei JC
Front Pharmacol; 2020; 11():607. PubMed ID: 32457614
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
14. Possible Association between the Use of Proton Pump Inhibitors and H
Choi HG; Lee HK; Kang HS; Lim H; Kim JH; Kim JH; Kim NY; Cho SJ; Nam ES; Min KW; Kwon MJ
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631344
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA
Am J Gastroenterol; 2020 May; 115(5):706-715. PubMed ID: 32205645
[TBL] [Abstract][Full Text] [Related]
16. Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort.
Choi HG; Kim JH; Kim JH; Kim ES; Park HY; Min KW; Kwon MJ
Alzheimers Res Ther; 2022 Jul; 14(1):91. PubMed ID: 35773740
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
18. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
20. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
